Tamiflu touted for child use

The maker of the anti-viral Tamiflu said the drug is effective for treatment and prevention of influenza in young children.

Data presented at the World Society for Pediatric Infectious Disease meeting in Bangkok this week said Tamiflu (oseltamivir) significantly reduces illness severity and duration of influenza in children ages 1 and older, particularly if given within 24 hours of symptom onset, Roche pharmaceuticals said Thursday in a release.

Roche pharmaceuticals said it will offer child-sized Tamiflu capsules of 30 mg and 45 mg doses to provide easier and more convenient dosing by parents.

The company said Tamiflu was shown to reduce influenza severity by 52 percent, and illness duration was reduced by 34 percent if treatment was started within 24 hours of onset.

Copyright 2007 by United Press International

Related stories:

Faster test reported for detecting fake Tamiflu in fight against counterfeit drugs
Chemists in Georgia are reporting development of a fast new method to detect fake Tamiflu, the mainstay medication for preventing and treating bird flu. Tamiflu has become a target for counterfeiters as recent outbreaks of bird flu have increased public demand for supplies of just-in-case antiviral drugs to use in case of an epidemic of the deadly disease.
Scientists examine bird flu infections to monitor for 'pandemic' mutations
Scientists funded by the Wellcome Trust are to examine what is preventing the H5N1 avian influenza virus from causing a human pandemic and what mutations are required to realise its deadly potential. The research could hold the key to early identification of a potential influenza pandemic, and to developing drugs and a vaccine.
Indonesia probes bird flu 'outbreak'
Indonesia has rushed a team of specialists to a village in Sumatra to confirm a suspected outbreak of bird flu which has affected at least 13 people, a health official said Thursday.
Researchers identify potential new drug candidates to combat 'bird flu'
As the specter of a worldwide outbreak of avian or "bird flu" lingers, health officials recognize that new drugs are desperately needed since some strains of the virus already have developed resistance to the current roster of anti-flu remedies.
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
Researchers identify and shut down makers of fake anti-malarial medications
Georgia Institute of Technology researchers were part of a three-continent, multi-organizational effort known as “Operation Jupiter” that successfully identified and shut down manufacturers who were flooding Southeast Asia with counterfeit – and ineffective – anti-malarial drugs.
Mutated flu virus resists medicine
The Switzerland-based World Heath Organization said a small percentage of the major influenza virus this season has developed resistance to Tamiflu treatment.
WHO data confirms low level of resistance to Tamiflu
New data published by the World Health Organisation (WHO) has confirmed a low frequency of resistance to Tamiflu (oseltamivir) over 3 influenza seasons (2003 – 2006).

News discussion:

Medicine & Health news